We are live on ! Find out more
CCM

Cinctive Capital Management Portfolio holdings

AUM $1.53B
1-Year Est. Return 48.83%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+48.83%
3 Year Est. Return
+143.95%
5 Year Est. Return
+199.46%
10 Year Est. Return
–
AUM
$2.04B
AUM Growth
-$97.4M
Cap. Flow
-$113M
Cap. Flow %
-5.55%
Top 10 Hldgs %
11.33%
Holding
698
New
210
Increased
118
Reduced
125
Closed
177

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$18.9M
2
BAX icon
Baxter International
BAX
+$18.2M
3
EXE
Expand Energy Corp
EXE
+$17M
4
TMUS icon
T-Mobile US
TMUS
+$16.5M
5
MRK icon
Merck
MRK
+$16.3M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$22.2M
2
PLAN
Anaplan, Inc.
PLAN
+$21M
3
PAYC icon
Paycom
PAYC
+$19.5M
4
CNQ icon
Canadian Natural Resources
CNQ
+$14.1M
5
GILD icon
Gilead Sciences
GILD
+$13.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Technology 17.87%
3 Consumer Discretionary 12.08%
4 Financials 10%
5 Energy 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SFT
426
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$783K 0.04%
11,278
+4,295
+62% +$344K
APP icon
427
Applovin
APP
$133B
$764K 0.04%
10,550
+4,550
+76% +$309K
CORZ
428
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$758K 0.04%
74,994
-100,000
-57% -$1M
DAR icon
429
Darling Ingredients
DAR
$9.64B
$742K 0.04%
+10,313
New +$738K
EVLO
430
PUT
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$724K 0.04%
+5,145
New +$1.02M
CALM icon
431
Cal-Maine
CALM
$4.12B
$723K 0.04%
+20,000
New +$713K
PTGX icon
432
Protagonist Therapeutics
PTGX
$8.79B
$716K 0.04%
+40,387
New +$1.72M
STE icon
433
Steris
STE
$22.3B
$713K 0.03%
3,488
-31,944
-90% -$6.83M
IMDX
434
Insight Molecular Diagnostics
IMDX
$150M
$710K 0.03%
9,978
+1,978
+25% +$182K
RVTY icon
435
Revvity
RVTY
$12.6B
$697K 0.03%
+4,020
New +$708K
REGI
436
DELISTED
Renewable Energy Group, Inc.
REGI
$696K 0.03%
+13,871
New +$759K
CVRX icon
437
CVRx
CVRX
$137M
$695K 0.03%
42,000
-48,000
-53% -$921K
ISEE
438
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$691K 0.03%
+42,523
New +$463K
CRSP icon
439
CRISPR Therapeutics
CRSP
$4.73B
$672K 0.03%
+6,000
New +$754K
SGRY icon
440
Surgery Partners
SGRY
$2.01B
$635K 0.03%
+15,000
New +$765K
ANGI icon
441
Angi Inc
ANGI
$229M
$630K 0.03%
+5,104
New +$587K
DNA icon
442
CALL
Ginkgo Bioworks
DNA
$528M
$580K 0.03%
+1,250
New +$609K
FWONK icon
443
Liberty Media Series C
FWONK
$24.6B
$575K 0.03%
11,576
-18,451
-61% -$873K
IMGN
444
DELISTED
Immunogen Inc
IMGN
$567K 0.03%
+100,000
New +$578K
STMP
445
DELISTED
Stamps.com, Inc.
STMP
$567K 0.03%
+1,718
New +$545K
VERV
446
DELISTED
Verve Therapeutics
VERV
$564K 0.03%
+12,000
New +$706K
QNCX icon
447
Quince Therapeutics
QNCX
$22.9M
$550K 0.03%
30
-10
-25% -$159K
RCKT icon
448
Rocket Pharmaceuticals
RCKT
$340M
$538K 0.03%
+18,000
New +$655K
VTIQ
449
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$537K 0.03%
54,991
– –
HMCOW
450
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$516K 0.03%
486,368
– –
16 17
18
19 20

Similar funds

MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
FI
FJ Investments Salt Lake City, Utah $1.53B AUM 27.51% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.53B AUM 18.11% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
HR
Howe & Rusling Rochester, New York $1.53B AUM 21.45% 1-Year Est. Return
CCP
Cryder Capital Partners London, United Kingdom $1.53B AUM 9.36% 1-Year Est. Return

Cinctive Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Cinctive Capital Management held 698 positions worth $2.04B, down 4.6% from $2.14B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cinctive Capital Management withdrew a net $113M in Q3 2021, closing 177 positions and reducing 125 holdings. Its most notable exit was Canadian Natural Resources, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Cinctive Capital Management opened a new position in Thermo Fisher Scientific worth $19.7M.

  • Cinctive Capital Management's largest Q3 2021 buy was Thermo Fisher Scientific: 34,421 shares worth $19.7M.
  • Cinctive Capital Management added most to Eli Lilly in Q3 2021, an estimated $11.2M increase.
  • Cinctive Capital Management's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $22.2M.
  • Cinctive Capital Management fully exited Canadian Natural Resources in Q3 2021, selling an estimated $14.1M.
  • Cinctive Capital Management's ten largest holdings make up 11% of its $2.04B portfolio in Q3 2021.
  • Cinctive Capital Management opened 210 new positions and closed 177 in Q3 2021.
  • Cinctive Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.04B.

Based on Cinctive Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.